Pictet Asset Management (UK)’s Dr. Reddy's Laboratories RDY Stock Holding History

Pictet Asset Management (UK)’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-43,945	Closed	-$398K	–	870
2016 Q4	$398K	Hold	43,945	–	–	﹤0.01%	827
2016 Q3	$408K	Sell	43,945 -224,825	-84%	-$2.15M	﹤0.01%	810
2016 Q2	$2.54M	Hold	268,770	–	–	0.01%	713
2016 Q1	$2.36M	Buy	268,770 +30,000	+13%	+$268K	0.01%	669
2015 Q4	$2.21M	Sell	238,770 -190,330	-44%	-$2.08M	0.01%	708
2015 Q3	$5.49M	Sell	429,100 -122,335	-22%	-$1.52M	0.02%	530
2015 Q2	$7.1M	Buy	551,435 +158,175	+40%	+$1.75M	0.03%	498
2015 Q1	$4.09M	Sell	393,260 -155,685	-28%	-$1.65M	0.02%	622
2014 Q4	$5.54M	Sell	548,945 -37,270	-6%	-$392K	0.02%	551
2014 Q3	$6.16M	Buy	586,215 +161,620	+38%	+$1.52M	0.03%	483
2014 Q2	$3.66M	Sell	424,595 -91,110	-18%	-$766K	0.02%	626
2014 Q1	$4.53M	Sell	515,705 -111,645	-18%	-$971K	0.02%	554
2013 Q4	$5.15M	Sell	627,350 -260,720	-29%	-$2.06M	0.03%	498
2013 Q3	$6.71M	Sell	888,070 -328,135	-27%	-$2.39M	0.04%	441
2013 Q2	$9.2M	Buy	+1,216,205	New	+$8.88M	0.05%	338

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Pictet Asset Management (UK)'s RDY Position: Q1 2017 in Review

Pictet Asset Management (UK) sold out of Dr. Reddy's Laboratories (RDY) in Q1 2017, closing a stake of 43,945 shares — an estimated $398K sold.

Pictet Asset Management (UK) first reported a position in RDY in Q2 2013 and held it in 15 quarters. The position peaked at $9.2M in Q2 2013. 134 funds tracked by Wall St. Rank hold RDY as of Q1 2017.

Pictet Asset Management (UK) reported no remaining Dr. Reddy's Laboratories position as of Q1 2017 after selling out during the quarter.
Pictet Asset Management (UK) sold 43,945 Dr. Reddy's Laboratories shares in Q1 2017, an estimated $398K.
Pictet Asset Management (UK) first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 15 quarters.
Pictet Asset Management (UK)'s Dr. Reddy's Laboratories position peaked at $9.2M in Q2 2013.
134 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2017.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2017, filed 4 May 2017.